ACM
Avalon Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-54,500
| Closed | -$4.53M | – | 73 |
|
|
2023
Q2 | $4.53M | Buy |
54,500
+427
| +0.8% | +$35.5K | 2.12% | 19 |
|
|
2023
Q1 | $4.12M | Sell |
54,073
-1,117
| -2% | -$85.1K | 2.11% | 17 |
|
|
2022
Q4 | $4.58M | Buy |
55,190
+113
| +0.2% | +$9.38K | 2.31% | 14 |
|
|
2022
Q3 | $4.37M | Sell |
55,077
-1,086
| -2% | -$86.1K | 2.09% | 14 |
|
|
2022
Q2 | $4.17M | Buy |
+56,163
| New | +$4.17M | 1.71% | 16 |
|
|
2018
Q4 | – | Sell |
-57,740
| Closed | -$5.54M | – | 60 |
|
|
2018
Q3 | $5.54M | Buy |
57,740
+37,116
| +180% | +$3.56M | 5.06% | 6 |
|
|
2018
Q2 | $1.96M | Buy |
20,624
+2,109
| +11% | +$201K | 1.95% | 18 |
|
|
2018
Q1 | $1.62M | Sell |
18,515
-17,665
| -49% | -$1.55M | 1.6% | 19 |
|
|
2017
Q4 | $3.07M | Sell |
36,180
-13,415
| -27% | -$1.14M | 2.74% | 8 |
|
|
2017
Q3 | $4.29M | Buy |
49,595
+10,964
| +28% | +$949K | 2.97% | 4 |
|
|
2017
Q2 | $2.98M | Buy |
38,631
+13,170
| +52% | +$1.02M | 2.2% | 14 |
|
|
2017
Q1 | $1.77M | Buy |
25,461
+21,056
| +478% | +$1.46M | 1.22% | 31 |
|
|
2016
Q4 | $261K | Sell |
4,405
-26,464
| -86% | -$1.57M | 0.2% | 71 |
|
|
2016
Q3 | $2.05M | Buy |
+30,869
| New | +$2.05M | 1.57% | 21 |
|
|
2015
Q3 | – | Sell |
-4,910
| Closed | -$1.24M | – | 87 |
|
|
2015
Q2 | $1.24M | Sell |
4,910
-5,625
| -53% | -$1.42M | 1.13% | 38 |
|
|
2015
Q1 | $2.38M | Sell |
10,535
-10,567
| -50% | -$2.38M | 1.92% | 22 |
|
|
2014
Q4 | $3.94M | Buy |
+21,102
| New | +$3.94M | 3.03% | 8 |
|
|
2014
Q2 | – | Sell |
-2,754
| Closed | -$392K | – | 117 |
|
|
2014
Q1 | $392K | Buy |
+2,754
| New | +$392K | 0.32% | 81 |
|